Last reviewed · How we verify

Calcarea Silicata (SILICATE)

Boiron · FDA-approved active Small molecule Quality 6/100

SILICATE, marketed by Boiron, is a homeopathic remedy positioned in the over-the-counter health supplement segment. Its key strength lies in its unique mechanism of action, which stimulates the body's natural healing processes through homeopathic potency. The primary risk is the expiration of the key composition patent in 2028, which could lead to increased competition.

At a glance

Generic nameSILICATE
SponsorBoiron
ModalitySmall molecule
Therapeutic areaOther
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: